Clinical trial

Neurogenic Intermittent Claudication Evaluation Study

NCT00905359 · Medtronic Spinal and Biologics, Industry · Completed

Key facts

NCT number NCT00905359
Title Neurogenic Intermittent Claudication Evaluation Study
Official title A Multicenter Prospective Randomized Controlled Clinical Trial to Evaluate the Effectiveness and Safety of the Aperius™ PercLID™ System Versus Standalone Decompressive Surgery in Degenerative Lumbar Spinal Stenosis With Neurogenic Intermittent Claudication
Acronym NICE
Lead sponsor Medtronic Spinal and Biologics, Industry
Status Completed
Phase Phase 4
Study type Interventional
Conditions Spinal Stenosis
Intervention type Procedure
Interventions Aperius™ PercLID™ System, Standalone Decompressive Surgery
Enrollment 163
Start date Jan 1, 2010
Primary completion Sep 1, 2014
Completion Apr 1, 2015
First posted May 20, 2009
Last update posted Feb 10, 2017
Countries Australia, Belgium, France, Germany, Iceland, Italy, Poland, Singapore, Sweden, United Kingdom

At a glance

  • 10–99 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies